Chewing substances with or without tobacco and risk of cardiovascular disease in Asia: a meta-analysis.
OBJECTIVE
To assess whether people who ever use any form of chewing substance in Asia are at increased risk of cardiovascular disease (CVD).


METHODS
PubMed and ISI Web of Science were searched for relevant studies, with no limitation on language or study year. Studies were included if they provided quantitative estimate of the association between ever use of chewing substance and the occurrence of CVD. Two authors independently implemented inclusion criteria, abstracted study characteristics, and performed meta-analysis. Summary relative risks were estimated on the basis of a random effect model. We used Q statistic and Egger's test to examine heterogeneity across studies and potential publication bias, respectively.


RESULTS
Eight eligible studies were included. The relative risk of CVD for ever using chewing substances with or without tobacco was 1.26 (95% confidence interval (CI) 1.12-1.40), which was unchanged when restricted to cohort studies [1.25 (1.08-1.42)] or cohort studies in Taiwan [1.31 (1.12-1.51)]. The summary relative risk for ischemic heart disease was 1.27 (1.02-1.52), and was lowered to 1.26 (0.85-1.67) after exclusion of a cross-sectional study. The overall relative risk for cerebrovascular disease was 1.32 (1.08-1.56). On the basis of the Taiwan data, the summary relative risk of CVD for betel (Areca catechu) chewing was 1.30 (1.17-1.44). Data on dose-response were limited to betel chewing in Taiwan, suggesting a relationship between risk of CVD and cumulative exposure. Two large cohorts in Taiwan reported a greater risk of CVD with betel chewing than with smoking.


CONCLUSIONS
An association was detected between betel chewing with or without tobacco and the risk of CVD. Betel chewing may impose a greater CVD risk than smoking. More effort is needed in developing betel chewing cessation programmes. The relationship between betel chewing and subgroups of CVD requires further investigation.
Zhang
Li-Na
LN
Department of Gerontology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
Yang
Yun-mei
YM
Xu
Zhe-rong
ZR
Gui
Qi-feng
QF
Hu
Qin-qing
QQ
D001114:Areca / Q000009:adverse effects*; D001208:Asia / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D012306:Risk; D014030:Tobacco, Smokeless / Q000009:adverse effects*
Oral Microbiol Immunol. 2001 Dec;16(6):364-9
11737660
Diabetes Care. 2006 Jul;29(7):1714
16801615
Am J Clin Nutr. 2008 Jan;87(1):70-8
18175739
Lancet. 2006 Aug 19;368(9536):647-58
16920470
JAMA. 2000 Apr 19;283(15):2008-12
10789670
Am J Clin Nutr. 2008 May;87(5):1204-11
18469240
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 May;95(5):559-69
12738947
Am J Clin Nutr. 2007 May;85(5):1229-35
17490957
Tob Control. 2005 Jun;14 Suppl 1:i16-22
15923442
J Assoc Physicians India. 2007 Jan;55:27-31
17444341
Control Clin Trials. 1986 Sep;7(3):177-88
3802833
J Assoc Physicians India. 2000 Sep;48(9):895-7
11198789
Am J Epidemiol. 2007 Mar 15;165(6):677-83
17204513
Int J Epidemiol. 2005 Dec;34(6):1395-402
16249218
BMJ. 2009 Aug 18;339:b3060
19690343
Hypertens Res. 2008 Mar;31(3):417-23
18497460
J Am Coll Cardiol. 1997 Jun;29(7):1422-31
9180099
Ann Acad Med Singap. 2004 Jul;33(4 Suppl):31-6
15389304
Tob Control. 2003 Dec;12(4):e4
14660785
Respirology. 2003 Dec;8(4):419-31
14708551
Public Health. 2008 Dec;122(12):1331-8
18657835
Addict Biol. 2002 Jan;7(1):103-10
11900629